These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9924849)
21. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure]. Buchwald A; Unterberg C; van der Does R; Wiegand V Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100 [TBL] [Abstract][Full Text] [Related]
22. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702 [TBL] [Abstract][Full Text] [Related]
23. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Krum H; Ninio D; MacDonald P Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738 [TBL] [Abstract][Full Text] [Related]
24. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. Krum H; Roecker EB; Mohacsi P; Rouleau JL; Tendera M; Coats AJ; Katus HA; Fowler MB; Packer M; JAMA; 2003 Feb; 289(6):712-8. PubMed ID: 12585949 [TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure. Cohen Solal A; Jondeau G; Beauvais F; Berdeaux A Eur J Heart Fail; 2004 Jun; 6(4):463-6. PubMed ID: 15182772 [TBL] [Abstract][Full Text] [Related]
26. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
27. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers. Lindenfeld J; Robertson AD; Lowes BD; Bristow MR; J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299 [TBL] [Abstract][Full Text] [Related]
28. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482 [TBL] [Abstract][Full Text] [Related]
29. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482 [TBL] [Abstract][Full Text] [Related]
30. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067 [TBL] [Abstract][Full Text] [Related]
32. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Fowler MB Am J Cardiol; 2004 May; 93(9A):35B-9B. PubMed ID: 15144935 [TBL] [Abstract][Full Text] [Related]
33. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572 [TBL] [Abstract][Full Text] [Related]
34. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Khattar RS; Senior R; Soman P; van der Does R; Lahiri A Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363 [TBL] [Abstract][Full Text] [Related]
35. Carvedilol: a review of its use in chronic heart failure. Keating GM; Jarvis B Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089 [TBL] [Abstract][Full Text] [Related]
37. Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure. Krum H; Gu A; Wilshire-Clement M; Sackner-Bernstein J; Goldsmith R; Medina N; Yushak M; Miller M; Packer M Am Heart J; 1996 Feb; 131(2):337-41. PubMed ID: 8579030 [TBL] [Abstract][Full Text] [Related]
38. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. Nodari S; Metra M; Dei Cas A; Dei Cas L Eur J Heart Fail; 2003 Dec; 5(6):803-9. PubMed ID: 14675859 [TBL] [Abstract][Full Text] [Related]